Courier Capital LLC Bristol Myers Squibb CO Transaction History

Courier Capital LLC

$1.44 Billion
Q3 2024

A detailed history of Courier Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Courier Capital LLC holds 43,046 shares of BMY stock, worth $2.53 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

43,046

Previous 44,020 2.21%

Holding current value

$2.53 Million

Previous $1.83 Million 21.83%

% of portfolio

0.15%

Previous 0.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$39.66 - $51.75 $38,628 - $50,404	-974 Reduced 2.21%	43,046 $2.23 Million
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $24,552 - $32,323	-610 Reduced 1.37%	44,020 $1.83 Million
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $90,346 - $102,435	-1,883 Reduced 4.05%	44,630 $2.42 Million
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $35,341 - $42,172	-729 Reduced 1.54%	46,513 $2.39 Million
Q3 2023 Oct 13, 2023	SELL	$57.89 - $64.73 $157,055 - $175,612	-2,713 Reduced 5.43%	47,242 $2.74 Million
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $480,182 - $533,167	7,537 Added 17.77%	49,955 $3.19 Million
Q1 2023 May 18, 2023	SELL	$65.71 - $74.53 $86,540 - $98,156	-1,317 Reduced 3.01%	42,418 $2.94 Million
Q4 2022 Jan 24, 2023	SELL	$68.48 - $81.09 $23,694 - $28,057	-346 Reduced 0.78%	43,735 $0
Q3 2022 Oct 18, 2022	BUY	$0.13 - $76.84 $345 - $204,317	2,659 Added 6.42%	44,081 $3.13 Million
Q2 2022 Jul 20, 2022	BUY	$72.62 - $79.98 $136,525 - $150,362	1,880 Added 4.75%	41,422 $3.19 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $221,328 - $265,392	-3,600 Reduced 8.34%	39,542 $2.89 Million
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $33,840 - $39,450	631 Added 1.48%	43,142 $2.69 Million
Q3 2021 Oct 14, 2021	BUY	$59.17 - $69.31 $1,420 - $1,663	24 Added 0.06%	42,511 $2.52 Million
Q2 2021 Jul 12, 2021	BUY	$61.91 - $67.42 $63,148 - $68,768	1,020 Added 2.46%	42,487 $2.84 Million
Q1 2021 Apr 12, 2021	BUY	$59.34 - $66.74 $58,865 - $66,206	992 Added 2.45%	41,467 $2.62 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $50,002 - $56,662	866 Added 2.19%	40,475 $2.51 Million
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $9,188 - $10,182	-160 Reduced 0.4%	39,609 $2.53 Million
Q2 2020 Jul 06, 2020	SELL	$54.82 - $64.09 $72,636 - $84,919	-1,325 Reduced 3.22%	39,769 $2.35 Million
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $370,550 - $538,495	-7,986 Reduced 16.27%	41,094 $2.49 Million
Q4 2019 Jan 10, 2020	SELL	$49.21 - $64.19 $73,913 - $96,413	-1,502 Reduced 2.97%	49,080 $3.21 Million
Q3 2019 Oct 04, 2019	SELL	$42.77 - $50.71 $44,951 - $53,296	-1,051 Reduced 2.04%	50,582 $2.51 Million
Q2 2019 Jul 16, 2019	SELL	$44.62 - $49.34 $87,098 - $96,311	-1,952 Reduced 3.64%	51,633 $2.34 Million
Q1 2019 Apr 25, 2019	SELL	$45.12 - $53.8 $2,256 - $2,690	-50 Reduced 0.09%	53,585 $2.56 Million
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $61,193 - $79,353	-1,255 Reduced 2.29%	53,635 $2.79 Million
Q3 2018 Oct 12, 2018	BUY	$55.19 - $62.25 $189,412 - $213,642	3,432 Added 6.67%	54,890 $3.41 Million
Q2 2018 Jul 19, 2018	BUY	$50.53 - $62.98 $10,712 - $13,351	212 Added 0.41%	51,458 $2.85 Million
Q1 2018 Apr 27, 2018	BUY	$59.92 - $68.98 $46,977 - $54,080	784 Added 1.55%	51,246 $3.24 Million
Q4 2017 Jan 25, 2018	BUY	$59.94 - $65.35 $6,833 - $7,449	114 Added 0.23%	50,462 $3.09 Million
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $492,927 - $568,879	8,925 Added 21.55%	50,348 $3.21 Million
Q2 2017 Aug 10, 2017	BUY	N/A	41,423	41,423 $2.31 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Courier Capital LLC with notifications on news.

Account

Courier Capital LLC Bristol Myers Squibb CO Transaction History